Table 4.

Secondary diagnoses where the direction of association differs across the examined dimensions

Diagnosis (CCS)	Is secondary diagnosis	Is non-POA diagnosis	Is chronic diagnosis
Peri-; endo-; myocarditis (97)		2.30 (1.58–3.34)	.77 (.62–.95)
Nephritis/renal sclerosis (156)	6.70 (1.98–22.62)		.19 (.05–.67)
Coma; stupor; brain damage (85)	4.46 (3.80–5.22)		.50 (.40–.62)
Peripheral and visceral atheroscler. (114)	2.76 (1.97–3.85)	3.04 (1.79–5.16)	.44 (.32–.62)
Respiratory failure; arrest (131)	2.48 (2.30–2.67)	1.50 (1.36–1.65)	.81 (.75–.87)
Unspec Neopl/of uncertain behavior (44)	1.54 (1.21–1.95)		.63 (.57–.70)
Intestinal obstruction w/o hernia (145)	1.51 (1.29–1.78)	.62 (.41–.83)
Fluid and electrolyte disorders (55)	1.37 (1.29–1.45)	.75 (.69–.81)
Chronic ulcer of skin (199)	1.26 (1.16–1.37)	.57 (.39–.83)
Nutritional; endocrine; metabolic (58)	1.21 (1.10–1.31)	.82 (.69–.96)	.63 (.57–.70)
Congestive heart failure (108)	1.12 (1.05–1.19)	.75 (.64–.88)
Bacterial infection (3)	.79 (.72–.88)	1.51 (1.13–2.02)
Other nervous system disorders (95)	.79 (.72–.87)	1.17 (1.04–1.31)	1.45 (1.32–1.60)
COPD (127)	.51 (.34–.77)		1.99 (1.32–3.01)